Indication

Supraventricular tachycardia

Supraventricular tachycardia refers to a broad category of cardiac tachyarrhythmias that originate at or above the bundle of His or require atrial or atrioventricular nodal tissue for their initiation and maintenance. Read more about Supraventricular tachycardia

31 drugs 19 manufacturers

Advertisement

Drugs that treat it

Common Supraventricular tachycardia therapies.

Showing 1–9 of 31 drugs

ESMOLOL HCL

BETA-BLOCKERS (SYSTEMIC)·PERIOPERATIVE HYPERTENSION·+3
Baxter Healthcare Company

ESMOLOL HCL

PERIOPERATIVE HYPERTENSION·+3
APP PHARMACEUTI

PROPRANOLOL HCL

BETA-BLOCKERS (SYSTEMIC)·SUPRAVENTRICULAR TACHYCARDIA·+3
BEDFORD LABS
Filter & compare in the drug finder →Opens the drug finder with Supraventricular tachycardia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Supraventricular tachycardia.

Supraventricular tachycardia refers to a broad category of cardiac tachyarrhythmias that originate at or above the bundle of His or require atrial or atrioventricular nodal tissue for their initiation and maintenance.

Affecting both pediatric and adult populations, the condition commonly encompasses entities such as atrioventricular nodal reentrant tachycardia, atrioventricular reciprocating tachycardia, and atrial tachycardia.

It is pathologically driven by reentrant electrical circuits, enhanced abnormal automaticity, or triggered activity within the conduction system.

Clinically, it typically manifests as a narrow-complex tachycardia with rapid, regular heart rates frequently ranging between 150 and 220 beats per minute, which may produce palpitations, presyncope, dyspnea, or hemodynamic compromise.

Personalize your experience

Follow Supraventricular tachycardia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it